# UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 32% Potential Upside in the Medical Devices Sector

- Link: https://www.directorstalkinterviews.com/ufp-technologies-inc-ufpt-stock-analysis-exploring-a-32-potential-upside-in-the-medical-devices-sector/4121257205
- Published: 2026-07-21T10:17:50+01:00
- Author: Madison Wilson

UFP Technologies, Inc. (NASDAQ: UFPT) is drawing considerable attention from investors,
given its strategic positioning within the healthcare sector, specifically in medical
devices. With a market capitalization of $1.9 billion, this U.S.-based company is
a notable player in the design and manufacturing of solutions for medical devices,
sterile packaging, and a variety of custom-engineered products.

The stock currently trades at $245.61, reflecting a modest price change of 0.01%
on the day. Its 52-week range has seen lows of $185.28 and highs up to $272.36, 
indicating a robust performance over the year. A key highlight for investors is 
the potential upside of 32.12%, based on an average analyst target price of $324.50,
with a high target of $360.00. This significant potential upside positions UFPT 
as a compelling opportunity for growth-focused investors.

In terms of valuation, the stock’s forward P/E ratio stands at 21.01, suggesting
that the market anticipates continued earnings growth. Despite the absence of trailing
P/E, PEG, and Price/Book ratios, the forward-looking metrics provide a glimpse into
the company’s valuation against its future earnings potential.

UFP Technologies has demonstrated steady revenue growth at 4.10%, indicating resilience
and consistent performance. The company boasts an impressive EPS of 8.92, coupled
with a strong return on equity of 17.17%, showcasing effective management and profitability.
Its free cash flow of $53.57 million further underscores financial health, providing
the liquidity needed to fuel future expansion and innovation.

Dividend-seeking investors may note the absence of a dividend yield, as UFP Technologies
currently does not distribute dividends, opting instead to reinvest earnings into
growth opportunities—a strategy that appears to be yielding positive results.

Analyst sentiment offers a balanced outlook with two buy ratings and two hold ratings,
and no sell ratings, reflecting confidence in the company’s strategic direction.
The technical indicators also present a mixed picture; the stock trades above both
its 50-day and 200-day moving averages, at $235.79 and $222.89 respectively, indicating
an upward trend. However, the RSI of 39.45 suggests the stock is closer to being
oversold, offering a potential entry point for investors.

UFP Technologies serves a diverse clientele across medical, aerospace, defense, 
automotive, and consumer sectors. This diversification, alongside its innovative
product offerings—from protective drapes for surgical procedures to components for
cardiac implants—positions the company well within its industry.

Founded in 1963 and headquartered in Newburyport, Massachusetts, UFP Technologies
continues to leverage its decades of experience in providing specialized solutions
across various industries. Its commitment to innovation and quality, coupled with
a robust sales strategy, has enabled sustained growth and market expansion.

For investors eyeing the medical devices sector, UFP Technologies presents a promising
opportunity. With its solid financial footing, growth potential, and strategic market
position, UFPT remains a stock worth watching for those looking to capitalize on
the healthcare industry’s evolving landscape.

Share on:
